» Articles » PMID: 10530813

Group 1 MGlu Receptors Elevate [Ca2+]i in Rat Cultured Cortical Type 2 Astrocytes: [Ca2+]i Synergy with Adenosine A1 Receptors

Overview
Specialties Neurology
Pharmacology
Date 1999 Oct 26
PMID 10530813
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Brain macroglia are known to express a diverse array of neurotransmitter receptors whose signal transduction pathways may be subject to heteroreceptor 'cross-talk'. In the current study we have examined group 1 mGlu receptor-evoked [Ca2+]i signalling, and possible heteroreceptor cross-talk, in cultured type 2 astrocytes. The selective group 1 metabotropic glutamate (mGlu) receptor agonist (S)-3,5-dihydroxyphenylglycine (DHPG) elevated [Ca2+]i (EC50 = 1.7 +/- 0.6 microM); an effect reversed by the selective mGlu receptor antagonist (S)-alpha-methyl-4-carboxyphenylglycine (IC50 = 52.7 +/- 8.7 microM). DHPG-evoked [Ca2+]i responses were abolished by (1) thapsigargin (100 nM), implicating the involvement of internal Ca2+ stores in group 1 mGlu [Ca2+]i responses and (2) the removal of extracellular Ca2+. When applied alone, the selective adenosine A1 receptor agonist, N6-cyclopentyladenosine (CPA, 100 nM) failed to influence [Ca2+]i. However, in the presence of 1 microM DHPG, CPA potently (EC50 = 12.3 +/- 1.9 nM) increased [Ca2+]i responses. In the presence of 100 nM CPA, the efficacy of DHPG was doubled without any significant change in the DHPG EC50 value. This effect was reversed by either the selective adenosine A1 receptor antagonist, 8-cyclopentyltheophylline (IC50 = 50.3 +/- 19.9 nM) or overnight incubation with Pertussis toxin (100 ng/ml). We conclude that (1) type 2 astrocytes contain group 1 mGlu receptors coupled to [Ca2+]i signalling and (2) co-activation of adenosine A1 receptors enhances group 1 mGlu-evoked [Ca2+]i responses in these cells via a Gi/o G protein-mediated mechanism.

Citing Articles

Molecular regulation of PLCβ signaling.

Ubeysinghe S, Wijayaratna D, Kankanamge D, Karunarathne A Methods Enzymol. 2023; 682:17-52.

PMID: 36948701 PMC: 11863860. DOI: 10.1016/bs.mie.2023.01.001.


Adenosine receptor signalling in Alzheimer's disease.

Trinh P, Baltos J, Hellyer S, May L, Gregory K Purinergic Signal. 2022; 18(3):359-381.

PMID: 35870032 PMC: 9391555. DOI: 10.1007/s11302-022-09883-1.


Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers.

Maggio R, Fasciani I, Carli M, Petragnano F, Marampon F, Rossi M Biomolecules. 2021; 11(12).

PMID: 34944469 PMC: 8698773. DOI: 10.3390/biom11121828.


Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors.

Leon-Navarro D, Albasanz J, Martin M Curr Neuropharmacol. 2018; 17(5):422-437.

PMID: 29663888 PMC: 6520591. DOI: 10.2174/1570159X16666180416093717.


Physiology of Astroglia.

Verkhratsky A, Nedergaard M Physiol Rev. 2018; 98(1):239-389.

PMID: 29351512 PMC: 6050349. DOI: 10.1152/physrev.00042.2016.